DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DPP-IV inhibitor anagliptin exerts anti-inflammatory effects on macrophages, adipocytes, and mouse livers by suppressing NF-κB activation
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
Volume 309, Issue 3, Pages E214-E223
Publisher
American Physiological Society
Online
2015-05-27
DOI
10.1152/ajpendo.00553.2014
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Glucagon-Like Peptide-1 Receptor Agonists for Diabetes Mellitus
- (2014) Nathaniel R. Smilowitz et al. CIRCULATION
- Prevention of Obesity-Induced Renal Injury in Male Mice by DPP4 Inhibition
- (2014) Ravi Nistala et al. ENDOCRINOLOGY
- Deficiency in adipocyte chemokine receptor CXCR4 exacerbates obesity and compromises thermoregulatory responses of brown adipose tissue in a mouse model of diet-induced obesity
- (2014) Longbiao Yao et al. FASEB JOURNAL
- Activated Monocytes: Yet Another Link Between Systemic Inflammation and Obesity
- (2014) Robert V. Considine JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of interleukins in obesity: implications for metabolic disease
- (2014) Mark A. Febbraio TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Improves Endothelial Dysfunction in Association With Its Anti-Inflammatory Effects in Patients With Coronary Artery Disease and Uncontrolled Diabetes
- (2013) Junichi Matsubara et al. CIRCULATION JOURNAL
- Glucagon-Like Peptide 1 Reduces Endothelial Dysfunction, Inflammation, and Oxidative Stress Induced by Both Hyperglycemia and Hypoglycemia in Type 1 Diabetes
- (2013) A. Ceriello et al. DIABETES CARE
- Anagliptin, a DPP-4 Inhibitor, Suppresses Proliferation of Vascular Smooth Muscles and Monocyte Inflammatory Reaction and Attenuates Atherosclerosis in Male apo E-Deficient Mice
- (2013) Nasib Ervinna et al. ENDOCRINOLOGY
- When GLP-1 hits the liver: a novel approach for insulin resistance and NASH
- (2012) Yong Ook Kim et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- An emerging role of dipeptidyl peptidase 4 (DPP4) beyond glucose control: Potential implications in cardiovascular disease
- (2012) Jixin Zhong et al. ATHEROSCLEROSIS
- Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes
- (2012) Y.-S. Lee et al. DIABETOLOGIA
- AMPK regulates macrophage polarization in adipose tissue inflammation and NASH
- (2012) Shih-Yen Weng et al. JOURNAL OF HEPATOLOGY
- Adipose Tissue Macrophages: MR Tracking to Monitor Obesity-associated Inflammation
- (2012) Alain Luciani et al. RADIOLOGY
- Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes
- (2011) Misaki Iwashita et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
- (2011) J. Shirakawa et al. DIABETES
- Beneficial Effect of a CXCR4 Agonist in Murine Models of Systemic Inflammation
- (2011) Hongkuan Fan et al. INFLAMMATION
- Peptidomics of the Prolyl Peptidases
- (2010) Anna Mari Lone et al. AAPS Journal
- Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice
- (2010) A. D. Dobrian et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Macrophages, Inflammation, and Insulin Resistance
- (2010) Jerrold M. Olefsky et al. Annual Review of Physiology
- The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression
- (2010) L. Sanchez-Martin et al. BLOOD
- The C type natriuretic peptide receptor tethers AHNAK1 at the plasma membrane to potentiate arachidonic acid-induced calcium mobilization
- (2009) Abdel A. Alli et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
- (2009) Roger Yazbeck et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
- (2008) Leonie Heilbronn et al. CURRENT PHARMACEUTICAL DESIGN
- Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats
- (2008) Yasushi Kirino et al. JOURNAL OF ENDOCRINOLOGY
- DP IV/CD26, APN/CD13 and related enzymes as regulators of T cell immunity: implications for experimental encephalomyelitis and multiple sclerosis
- (2007) Dirk Reinhold Frontiers in Bioscience-Landmark
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now